DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...
Hosted on MSN59m
INNOVATE Corp. announces FDA approval of MediBeacon TGFRINNOVATE Corp. (VATE) announced that the U.S. FDA has approved the MediBeacon TGFR for the assessment of kidney function in patients with normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback